N. Azli

Docetaxel and Doxorubicin Compared With Doxorubicin and Cyclophosphamide as First-Line Chemotherapy for Metastatic Breast Cancer: Results of a Randomized, Multicenter, Phase III Trial

Jean-Marc Nabholtz, Carla I. Falkson, J. Szántó et al. · Journal of Clinical Oncology · 2003 · 383 citations

Docetaxel is a major cytotoxic drug for the treatment of advanced breast cancer: a phase II trial of the Clinical Screening Cooperative Group of the European Organization for Research and Treatment of Cancer.

B Chevallier, P. Fumoleau, Pierre Kerbrat et al. · Journal of Clinical Oncology · 1995 · 222 citations

Treatment of advanced squamous cell carcinoma of the skin with cisplatin, 5-fluorouracil, and bleomycin

Hussein Sadek, N. Azli, J. L. Wendling et al. · Cancer · 1990 · 206 citations

Bolus Injection, Chemotherapy Combination, Surgical Oncology +11

Long-Term Disease-Free Survivors in Metastatic Undifferentiated Carcinoma of Nasopharyngeal Type

Abderrahim Fandi, M. Bachouchi, N. Azli et al. · Journal of Clinical Oncology · 2000 · 183 citations

Chemotherapy of metastatic and/or recurrent undifferentiated nasopharyngeal carcinoma with cisplatin, bleomycin, and fluorouracil.

Hamouda Boussen, Esteban Cvitkovic, J. L. Wendling et al. · Journal of Clinical Oncology · 1991 · 134 citations

Bone Mts, Surgical Oncology, Radiation Therapy +11